T

TOT BIOPHARM International Co Ltd
HKEX:1875

Watchlist Manager
TOT BIOPHARM International Co Ltd
HKEX:1875
Watchlist
Price: 4.1 HKD 0.99% Market Closed
Market Cap: HK$3.2B

Income Statement

Earnings Waterfall
TOT BIOPHARM International Co Ltd

Income Statement
TOT BIOPHARM International Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Revenue
Interest Expense
2
6
7
5
5
7
10
0
Revenue
76
N/A
235
+208%
442
+88%
588
+33%
781
+33%
973
+25%
1 098
+13%
1 067
-3%
Gross Profit
Cost of Revenue
(49)
(63)
(72)
(126)
(207)
(272)
(316)
(308)
Gross Profit
27
N/A
172
+526%
371
+115%
462
+25%
574
+24%
701
+22%
782
+12%
759
-3%
Operating Income
Operating Expenses
(283)
(322)
(409)
(510)
(595)
(684)
(744)
(740)
Selling, General & Administrative
(76)
(137)
(263)
(399)
(506)
(589)
(683)
(692)
Research & Development
(187)
(196)
(129)
(131)
(83)
(100)
(68)
(69)
Depreciation & Amortization
(31)
0
(25)
0
(24)
0
(16)
0
Other Operating Expenses
11
11
9
21
18
6
23
20
Operating Income
(255)
N/A
(150)
+41%
(38)
+74%
(48)
-24%
(21)
+55%
17
N/A
38
+121%
18
-53%
Pre-Tax Income
Interest Income Expense
(0)
(11)
(9)
(3)
(1)
(6)
(10)
(10)
Non-Reccuring Items
(5)
(1)
(3)
1
(15)
(3)
7
(1)
Pre-Tax Income
(261)
N/A
(162)
+38%
(50)
+69%
(49)
+1%
(38)
+24%
9
N/A
35
+288%
7
-79%
Net Income
Tax Provision
0
0
0
(0)
(0)
0
0
0
Income from Continuing Operations
(261)
(162)
(50)
(49)
(38)
9
35
7
Income to Minority Interest
0
0
0
0
0
0
0
0
Net Income (Common)
(261)
N/A
(162)
+38%
(50)
+69%
(49)
+1%
(38)
+23%
9
N/A
35
+288%
7
-79%
EPS (Diluted)
-0.46
N/A
-0.28
+39%
-0.08
+71%
-0.07
+12%
-0.05
+29%
0.01
N/A
0.05
+400%
0.01
-80%